Top

Published in:

Open Access 01-12-2016 | Review

Biomaterials for hollow organ tissue engineering

Authors: Eseelle K. Hendow, Pauline Guhmann, Bernice Wright, Panagiotis Sofokleous, Nina Parmar, Richard M. Day

Published in: Fibrogenesis & Tissue Repair | Issue 1/2016

Abstract

Tissue engineering is a rapidly advancing field that is likely to transform how medicine is practised in the near future. For hollow organs such as those found in the cardiovascular and respiratory systems or gastrointestinal tract, tissue engineering can provide replacement of the entire organ or provide restoration of function to specific regions. Larger tissue-engineered constructs often require biomaterial-based scaffold structures to provide support and structure for new tissue growth. Consideration must be given to the choice of material and manufacturing process to ensure the de novo tissue closely matches the mechanical and physiological properties of the native tissue. This review will discuss some of the approaches taken to date for fabricating hollow organ scaffolds and the selection of appropriate biomaterials.

Cooper DKC. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent). 2012;25(1):49–57.

Butler JR, Ladowski JM, Martens GR, Tector M, Tector AJ. Special Issue: xenotransplantation recent advances in genome editing and creation of genetically modified pigs. Int J Surg. 2015;23:217–22.CrossRefPubMed

Reardon S. New life for pig-to-human transplants. 2015 [09/12/15]; Available at: http://www.nature.com/news/new-life-for-pig-to-human-transplants-1.18768.

Zhu N, Chen X. Biofabrication of tissue scaffolds. Advances in biomaterials science and biomedical applications. 2013.

Chan BP, Leong KW. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J. 2008;4(4):467–79.CrossRef

Hubbell JA. Biomaterials in tissue engineering. Nature. 1995;13(6):565–76.

Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367(9518):1241–6.CrossRefPubMed

Hamilton NJ, Kanani M, Roebuck DJ, Hewitt RJ, Cetto R, Culme-Seymour EJ, Toll E, Bates AJ, Comerford AP, McLaren CA, Butler CR, Crowley C, McIntyre D, Sebire NJ, Janes SM, O'Callaghan C, Mason C, De Coppi P, Lowdell MW, Elliott MJ, Birchall MA. Tissue-engineered tracheal replacement in a child: a 4-year follow-up study. Am J Transplant. 2015;15(10):2750–7.CrossRefPubMedPubMedCentral

Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372(9655):2023–30.CrossRefPubMed

10.

Dhandayuthapani B, Yoshida Y, Maekawa T, Kumar DS. Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci. 2011;1-19.

11.

Nam YS, Park TG. Biodegradable polymeric microcellular foams by modified thermally induced phase separation method. Biomaterials. 1999;20(19)1783–90.CrossRefPubMed

12.

Kaji H. Biofabrication techniques for biologically relevant tissue models and drug delivery devices, Micro-NanoMechatronics and Human Science (MHS), 2012 International Symposium. 2012.

13.

Sofokleous P, Stride E, Bonfield W, Edirisinghe M. Design, construction and performance of a portable handheld electrohydrodynamic multi-needle spray gun for biomedical applications. Mater Sci Eng C. 2013;33(1):213–23.CrossRef

14.

Hoch E, Tovar GE, Borchers K. Bioprinting of artificial blood vessels: current approaches towards a demanding goal. Eur J Cardio-Thorac. 2014;45(5):767–78.CrossRef

15.

Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015;6(2):105–21.CrossRefPubMedPubMedCentral

16.

Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011;49(12):823–64.CrossRef

17.

Martínez-Pérez CA, Olivas-Armendariz I, Carmona C, García-Casillas PE. Scaffolds for tissue engineering via thermally induced phase separation, advances in regenerative medicine. 2011 Available from: http://www.intechopen.com/books/advances-in-regenerative-medicine/scaffolds-for-tissue-engineering-via-thermally-induced-phase-separation.

18.

Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377–97.CrossRef

19.

You Y, Lee SW, Youk JH, Min BM, Lee SJ, Park WH. In vitro degradation behaviour of non-porous ultra-fine poly(glycolic acid)/poly(l-lactic acid) fibres and porous ultra-fine poly(glycolic acid) fibres. Polym Degrad Stab. 2005;90(3):441–8.CrossRef

20.

Lam KH, Nieuwenhuis P, Molenaar I, Esselbrugge H, Feijen J, Dijkstra PJ, Schakenraad JM. Biodegradation of porous versus non-porous poly(L-lactic acid) films. J Mater Sci Mater Med. 1994;5(4):181–9.CrossRef

21.

Nemeno-Guanzon JG, Lee S, Berg JR, Jo YH, Yeo JE, Nam BO, Koh YG, Lee JI. Trends in tissue engineering for blood vessels. J Biomed Biotechnol. 2012;2012:956345.CrossRefPubMedPubMedCentral

22.

BHF. Medicines for your heart. 2015 [09/12/15]; Available at: https://www.bhf.org.uk/heart-health/treatments/medication.

23.

Hong KU, Li QH, Guo Y, Patton NS, Moktar A, Bhatnagar A, Bolli R. A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol. 2013;108:346.CrossRefPubMedPubMedCentral

24.

Alberts B, Johnson A, Lewis J, et al. Blood vessels and endothelial cells, Molecular Biology of the Cell, vol. 4. New York: Garland Science; 2002.

25.

Meloni AE, Spencer M, Riu HL, Katare F, Mangialardi R, Oikawa G, Rodriguez-Arabaolaza A, Dang I, Mitchell Z, Reni K, Alvino C, Rowlinson VV, Livi J, Cesselli U, Angelini D, Emanueli G, Beltrami C, Madeddu P. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res. 2015;116:81–91.CrossRef

26.

Buijtenhuijs P, Buttafoco L, Poot AA, Daamen WF, van Kuppevelt TH, Dijkstra PJ, de Vos RA, Sterk LM, Geelkerken BR, Feijen J, Vermes I. Tissue engineering of blood vessels: characterization of smooth-muscle cells for culturing on collagen-and elastin-based scaffolds. Biotechnol Appl Biochem. 2004;39(2):141–9.CrossRefPubMed

27.

Skardal A, Zhang J, Prestwich GD. Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. Biomaterials. 2010;31(24):6373–3681.CrossRef

28.

Zhao X, Irvine SA, Agrawal A, Cao Y, Lim PQ, Tan SY, Venkatraman SS. 3D patterned substrates for bioartificial blood vessels—the effect of hydrogels on aligned cells on a biomaterial surface. Acta Biomater. 2015;26:159–68.CrossRefPubMed

29.

Yao L, Liu J, Andreadis ST. Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels. Pharm Res-Dordr. 2008;25(5):1212–21.CrossRef

30.

Singh RK, Seliktar D, Putnam AJ. Capillary morphogenesis in PEG-collagen hydrogels. Biomaterials. 2013;34(37):9331–40.CrossRefPubMedPubMedCentral

31.

Moon JJ, Saik JE, Poche RA. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials. 2010;31(14):3840–7.CrossRefPubMedPubMedCentral

32.

Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract. 2013;38:316–42.

33.

Adair TH, Montani JP. Angiogenesis. San Rafael (CA): Morgan & Claypool Publishers; 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53242/.

34.

Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21(2):314–25.CrossRefPubMed

35.

Bronzino JD, Peterson DR. Tissue engineering and artificial organ, vol. 4. Broken Sound Parkway (NW): Taylor & Francis; 2006. Available at: https://www.crcpress.com/Tissue-Engineering-and-Artificial-Organs/Bronzino-Peterson-Bronzino/9780849321238#googlePreviewContainer.

36.

Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Creation of long-lasting blood vessels. Nature. 2004;428(6979):138–9.CrossRefPubMed

37.

Rocha FG, Sundback CA, Krebs NJ, Leach JK, Mooney DJ, Ashley SW, Vacanti JP, Whang EE. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials. 2008;29(19):2884–90.CrossRefPubMedPubMedCentral

38.

Chen J, Zhang ZG, Li Y, Wang L, Xian Xu Y, Gautam SC, Lu M, Zhu Z, Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692–9.CrossRefPubMed

39.

UK, C.R. Stomach cancer mortality statistics. Cancer Statistics 2014 [09/12/15]; Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/stomach-cancer/mortality#heading-Zero.

40.

Society, A.C. Treatment choices by type and stage of stomach cancer. 2015 [10/12/15]; Available at: http://www.cancer.org/cancer/stomachcancer/detailedguide/stomach-cancer-treating-by-stage.

41.

Othman R, Morris GE, Shah DA, Hall S, Hall G, Wells K, Shakesheff KM, Dixon JE. An automated fabrication strategy to create patterned tubular architectures at cell and tissue scales. Biofabrication. 2015;7(2):025003.CrossRefPubMed

42.

Maemura T, Shin M, Kinoshita M, et al. A tissue-engineered stomach shows presence of proton pump and G-cells in a rat model, resulting in improved anemia following total gastrectomy. Artif Organs. 2008;32(3):234–9.CrossRefPubMed

43.

Maemura T, Kinoshita M, Shin M, et al. Assessment of a tissue-engineered gastric wall patch in a rat model. Artif Organs. 2012;36(4):409–17.CrossRefPubMed

44.

Sala FG, Kunisaki SM, Ochoa ER, et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res. 2009;156(2):205–12.CrossRefPubMed

45.

Gastroenterology, B.S.o. Acute management—inflammatory bowel disease. 2009 [15/01/16]; Available at: http://www.bsg.org.uk/clinical/commissioning-report/acute-inflammatory-bowel-disease.html.

46.

NHS. Inflammatory bowel disease 2015 [15/01/16]; Available at: http://www.nhs.uk/conditions/Inflammatory-bowel-disease/Pages/Introduction.aspx.

47.

NHS. Ulcerative colitis—treatment 2014 [15/01/16]; Available at: http://www.nhs.uk/Conditions/Ulcerative-colitis/Pages/Treatment.aspx.

48.

Nakase Y, Hagiwara A, Nakamura T, Kin S, Nakashima S, Yoshikawa T, Fukuda K, Kuriu Y, Miyagawa K, Sakakura C, Otsuji E, Shimizu Y, Ikada Y, Yamagishi H. Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng. 2006;12(2):403–12.CrossRefPubMed

49.

Lee M, Wu BM, Stelzner M, Reichardt HM, Dunn JC. Intestinal smooth muscle cell maintenance by basic fibroblast growth factor. Tissue Eng Part A. 2008;14(8):1395–402.CrossRefPubMed

50.

Bitar KN, Raghavan S. Intestinal tissue engineering: current concepts and future vision of regenerative medicine in the gut. Neurogastroenterol Motil. 2012;24(1):7–9.CrossRefPubMedPubMedCentral

51.

Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg. 2004;240(5):748–54.CrossRefPubMedPubMedCentral

52.

Chen MK, Badylak SF. Small bowel tissue engineering using small intestinal submucosa as a scaffold. J Surg Res. 2001;99(2):352–8.CrossRefPubMed

53.

Bitar KN, Zakhem E. Tissue engineering and regenerative medicine as applied to the gastrointestinal tract. Curr Opin Biotechnol. 2013;24(5):909–15.CrossRefPubMedPubMedCentral

54.

Zakhem E, Raghavan S, Gilmont RR, Bitar KN. Chitosan-based scaffolds for the support of smooth muscle constructs in intestinal tissue engineering. Biomaterials. 2012;33:4810–7.CrossRefPubMedPubMedCentral

55.

Rossi CA, Pozzobon M, De Coppi P. Advances in musculoskeletal tissue engineering: moving towards therapy. Organogenesis. 2010;6(6):167–72.CrossRefPubMedPubMedCentral

56.

Disorders, I.F.f.F.G. Prevalence of bowel incontinence. 2014 [09/12/15]; Available at: http://www.aboutincontinence.org/site/what-is-incontinence/prevalence/.

57.

Hunskaar, S., Lose, et al. Prevalence of stress urinary incontinence in women in four European countries. 2003 [09/12/15]; Available at: http://www.icsoffice.org/publications/2002/pdf/257.pdf

58.

Gerhard VA. endocrine cell types of the gastro-intestinal tract and pancreas of a reptile (Bitis arietans): an immunocytochemical study. 1986: University of The Witwatersrand, 1986. Typescript (Photocopy).

59.

Thakar R, Sultan AH. Management of obstetric anal sphincter injury. The Obstetrician & Gynaecologist. 2003;5(2):72–8.CrossRef

60.

Parmar N, Kumar L, Emmanuel A, Day RM. Prospective regenerative medicine therapies for obstetric trauma-induced fecal incontinence. Regen Med. 2014;9(6):831–40.CrossRefPubMed

61.

Knight T, Basu J, Rivera EA, Spencer T, Jain D, Payne R. Fabrication of a multi-layer three-dimensional scaffold with controlled porous micro-architecture for application in small intestine tissue engineering. Cell AdhMigr. 2013;3:267.

62.

Kilian KA, Bugarija B, Lahn BT, Mrksich M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci U S A. 2010;107(11):4872–7.CrossRefPubMedPubMedCentral

63.

Shi LB, Cai HX, Chen LK, Wu Y, Zhu SA, Gong XN, Xia YX, Ouyang HW, Zou XH. Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency. Biomaterials. 2014;35(5):1519–30.CrossRefPubMed

64.

Klauser A, Frauscher F, Strasser H, Helweg G, Kolle D, Strohmeyer D. Age-related rhabdosphincter function in female urinary stress incontinence: assessment of intraurethral sonography. J Ultrasound Med. 2004;23(5):631–7.PubMed

65.

Welkoborsky HJ, Hinni ML, Moebius H, Bauer L, Ostertag H. Microscopic examination of iatrogenic subglottic tracheal stenosis: observations that mayelucidate its histopathologic origin. Ann Otol Rhinol Laryngol. 2014;123(1):25–31.CrossRefPubMed

66.

Haykal S, Salna M, Waddell TK, Hofer SO. Advances in tracheal reconstruction. Plast Reconstr Surg Glob Open. 2014;2(7):e178.CrossRefPubMedPubMedCentral

67.

Nomoto Y, Suzuki T, Tada Y, Kobayashi K, Miyake M, Hazama A, Wada I, Kanemaru S, Nakamura T, Omori K. Tissue engineering for regeneration of the tracheal epithelium. Ann Otol Rhinol Laryngol. 2006;115(7):501–6.CrossRefPubMed

68.

Hong HJ, Lee JS, Choi JW, Min BH, Lee HB, Kim CH. Transplantation of autologous chondrocytes seeded on a fibrin/hyaluronan composite gel into tracheal cartilage defects in rabbits: preliminary results. Artif Organs. 2012;36(11):998–1006.CrossRefPubMed

69.

Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol. 1996;156(2):571–7.CrossRefPubMed

70.

Walles T. Bioartificial tracheal grafts: can tissue engineering keep its promise? Expert Rev Med Devices. 2004;1(2):241–50.CrossRefPubMed

71.

Shi H, Xu Z, Qin X, Zhao X, Lu D. Experimental study of replacing circumferential tracheal defects with new prosthesis. Ann Thorac Surg. 2005;79(2):672–6.CrossRefPubMed

72.

Lin CH, Hsu SH, Su JM. Surface modification of poly(epsilon-caprolactone) porous scaffolds using gelatin hydrogel as the tracheal replacement. J Tissue Eng Regen M. 2011;5(2):156–62.CrossRef

73.

Tatekawa Y, Kawazoe N, Chen GP, Shirasaki Y, Komuro H, Kaneki M. Tracheal defect repair using a PLGA-collagen hybrid scaffold reinforced by a copolymer stent with bFGF-impregnated gelatin hydrogel. Pediatr Surg Int. 2010;26(6):575–80.CrossRefPubMed

74.

Zang M, Zhang Q, Chang EI, Mathur AB, Yu P. Decellularized tracheal matrix scaffold for tissue engineering. Plast Reconstr Surg. 2012;130(3):532–40.CrossRefPubMed

75.

Gonzalez-Molina J, Riegler J, Southern P, Ortega D, Frangos CC, Angelopoulos Y, Husain S, Lythgoe MF, Pankhurst QA, Day RM. Rapid magnetic cell delivery for large tubular bioengineered constructs. J R Soc Interface. 2012;9(76):3008–16.CrossRefPubMedPubMedCentral

76.

Park JH, Hong JM, Ju YM, Jung JW, Kang HW, Lee SJ, Yoo JJ, Kim SW, Kim SH, Cho DW. A novel tissue-engineered trachea with a mechanical behavior similar to native trachea. Biomaterials. 2015;62:106–15.CrossRefPubMed

77.

Goldstein TA, Smith BD, Zeltsman D, Grande D, Smith LP. Introducing a 3-dimensionally printed, tissue-engineered graft for airway reconstruction: a pilot study. Otolaryngol Head Neck Surg. 2015;153(6):1001–6.CrossRefPubMed

78.

Zhao DE, Li RB, Liu WY, et al. Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study. Cardiovasc Thorac Ann. 2003;11(2):153–6.CrossRef

79.

Parhizkar M et al. Novel preparation of controlled porosity particle/fibre loaded scaffolds using a hybrid micro-fluidic and electrohydrodynamic technique. Biofabrication. 2014;6(14):045010.CrossRefPubMed

80.

Blaker JJ, Knowles JC, Day RM. Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery. Acta Biomaterials. 2008;4(2):264–72.CrossRef

81.

Park JH, Hong JM, Ju YM, Jung JW, Kang HW, Lee SJ, Yoo JJ, Kim SW, Kim SH, Cho DW, A novel tissue-engineered trachea with a mechanical behavior similar to native trachea. Biomaterials. 2015;62:106–15.CrossRefPubMed

82.

Doshi J, Reneker DH. Electrospinning process and applications of electrospun fibers. J Electron. 1995;35(2):1698–1703.

Title: Biomaterials for hollow organ tissue engineering
Authors: Eseelle K. Hendow
Pauline Guhmann
Bernice Wright
Panagiotis Sofokleous
Nina Parmar
Richard M. Day
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Fibrogenesis & Tissue Repair / Issue 1/2016
Electronic ISSN: 1755-1536
DOI: https://doi.org/10.1186/s13069-016-0040-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Age-dependent development of liver fibrosis in Glmp gt/gt mice

Matrix and cell phenotype differences in Dupuytren’s disease

Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts

Activation of hepatic stellate cell in Pten null liver injury model

Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis

Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials